Management of Bilateral Fetal Renal Cystic Lesions

Initial Diagnostic Approach

The American Academy of Pediatrics and the National Institute of Diabetes and Digestive and Kidney Diseases recommend obtaining detailed three-generation family history focusing on kidney disease, particularly ADPKD, as up to 50% of cases may represent de novo mutations 1, 2
Parental renal ultrasound examination should be performed, as this may reveal previously undetected ADPKD in parents and significantly alter diagnostic probability 3, 4
If positive family history of ADPKD exists, hyperechogenic and/or enlarged kidneys (>2 standard deviations) on fetal ultrasonography are suggestive of ADPKD 5, 6
The presence of echogenicity pattern, such as hyperechogenic kidneys with loss of corticomedullary differentiation, suggests ARPKD 7
The size and number of individual cysts, such as macroscopic cysts favoring ADPKD or microcysts causing echogenicity favoring ARPKD, are important diagnostic features 5

The International Society of Nephrology and the European Renal Association recommend differentiating between ARPKD, ADPKD, and other cystic nephropathies, as the prognosis ranges from benign to fatal depending on the underlying etiology 1, 2, 7
Genetic testing should be considered to identify specific genetic etiologies, such as PKHD1, DZIP1L, CYS1, PKD1, and PKD2 genes 1, 2, 7

The American College of Medical Genetics and Genomics recommends offering genetic testing in scenarios such as very-early-onset disease, bilateral severe cystic disease with oligohydramnios, and negative family history with multiple bilateral cysts 4, 8
Multi-gene panel testing is preferred over single-gene analysis, as unusual genetic constellations can radically alter phenotype and prognosis 4

The National Kidney Foundation recommends assessing severe disease indicators, such as severe bilateral structural cystic disease with oligohydramnios, and mild disease indicators, such as isolated mild bilateral echogenicity without significant enlargement 8
A normal fetal ultrasound does not exclude ADPKD diagnosis in an at-risk child, as cysts develop gradually and may not be detectable prenatally in milder phenotypes 6, 8

The American Academy of Pediatrics recommends explaining the wide spectrum of outcomes, discussing the value and implications of confirmatory genetic testing, and outlining reproductive options for future pregnancies 8
The National Society of Genetic Counselors recommends discussing the value and implications of confirmatory genetic testing, recognizing that results may guide pregnancy management decisions and inform recurrence risk 8

The American Academy of Pediatrics recommends performing postnatal renal ultrasound within the first week of life, assessing renal function, monitoring blood pressure, and evaluating for pulmonary hypoplasia and providing respiratory support as needed 8
Serial ultrasound monitoring is essential, with repeat ultrasound at 1 month, 3 months, 6 months, and 12 months of age, to document changes in cyst size, number, and kidney dimensions 3, 8

The National Kidney Foundation recommends annual standardized office blood pressure measurement, 24-hour ambulatory blood pressure monitoring if BP >75th percentile, and target BP <50th percentile for age, sex, and height 8
The American Heart Association recommends echocardiography to exclude left ventricular hypertrophy if hypertension develops, and renin-angiotensin system blockade as first-line antihypertensive therapy 3, 8

The National Society of Genetic Counselors recommends providing recurrence risk based on identified genetic etiology, discussing screening recommendations for at-risk siblings, and offering cascade genetic testing for extended family members if dominant inheritance confirmed 1, 3